StarZero All shows Try the podcast clipper →

Peter Parker

Managing General Partner, Mission BioCapital · 1 appearance on the record.

computed by AI from the episodes · how this works → · full disclaimer →

investorfounderexecutivemissionbiocapital.com ↗

Peter D. Parker is an early-stage life sciences investor who co-founded Mission BioCapital as well as biotechnology incubators including LabCentral and BioLabs. Previously, he established Ampersand Ventures' life sciences practice and served as CEO of Cequent Pharmaceuticals and Boston Heart Diagnostics.

20statements → 8claims → 3claims resolved → 33%fully supported → 3.75/5average certainty → 2.3/5average debate potential → ≈4.5/5argument clarity, estimated → 2said about them ↓

1 supported 0 partly supported 2 contradicted 5 not checkable as stated how the 8 claims stand · each chip opens the sources

3 predictions · 5 assertions · 1 opinion · 9 insights · 2 disclosures · every statement was checked. The predictions and assertions are the 8 claims: statements the public record can support or contradict. 3 are resolved, and 5 name no date, number or outcome precise enough to check. Everything else (opinions, insights, what ifs, disclosures) can never be settled by the record, so it carries no assessment.

The record, in short

What the tape says about how Peter argues and how the claims held up. Everything they said, and everything said about them, is in the tabs below.

Their most notable supported claim

Prediction Held up
No New Major Pharma Companies Will Be Built From Biotech VC
“There are very few, there won't be any new major pharmaceutical companies created out of biotech VC money anymore. Really all about creating companies that can exit to these people.”
Peter Parker Jun 11, 2018 ▶ 22:46 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital

Their most notable contradicted claim

Assertion Contradicted
Pharma Internal Research Headcount Dropped 5-6% Annually Over the Past Decade
“If you look at the last 10 years, the research headcount in pharma has gone down by five or six percentage points per annum, so they're half as big internal research, but now what they've done is created external R&D groups, so they're out shopping, and we hav…”
Peter Parker Jun 11, 2018 ▶ 24:49 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital

How they sound: speaking style how? →

229 words/min while actually speaking · 2.7 um and uh per 1k words

No argument clarity score for Peter Parker: no usable question→answer exchanges on raw tape (a fair score needs 8+). We do not score a sample that small. Roundtable and news formats yield far fewer direct exchanges than interviews. Their coarse estimate from 29 exchanges on the produced feed is ≈4.5/5, shown at half point precision because the sample is small and produced tape scores higher.

Measured by listening to 4,797 words across 1 episode, but every recording we have of Peter Parker is the aired feed, and an editor cleaned that audio before release. Some of the hesitation was cut before we ever heard it, so read these as floors: the true rates are at least this high. These are measurements of speaking style, not scores. How it's measured →

How the interview went all their pushback → series average →

Across 1 rated episode:

host pushback ▾ 1/10
pushed back at the host ▾ 1/10
setup questions received 80%

Everything Peter Parker said on 20VC that made the record, most notable first. Filter by type, assessment or year in the ledger →

Prediction Held up
No New Major Pharma Companies Will Be Built From Biotech VC
“There are very few, there won't be any new major pharmaceutical companies created out of biotech VC money anymore. Really all about creating companies that can exit to these people.”
Peter Parker Jun 11, 2018 ▶ 22:46 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital
Prediction Not checkable as stated
BioInnovation Capital Targets Gains on Two-Thirds of Portfolio Companies
“I'd like to see a portfolio with two thirds of my companies being gains for us. And so not relying on the 50 to one winner to Drive the whole portfolio. I think that's just too hard to do.”
Peter Parker Jun 11, 2018 ▶ 27:23 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital
Disclosure
BioInnovation Capital Requires Unanimous Partner Consensus to Invest
“We passed on deals where one partner had just serious reservations and four would have voted for it. And that was true at Ampersand. It's true at Bioinnovation Capital as well.”
Peter Parker Jun 11, 2018 ▶ 10:13 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital
Opinion
VCs Are Middlemen and the Cult of Personality Is Unwarranted
“My view of the world is we're middlemen. It's their capital, and we're finding great places to put it. That sounds pretty pedestrian. I really don't like the cult of Personality that sometimes accrues to very, very big names in the venture business. I'm not su…”
Peter Parker Jun 11, 2018 ▶ 11:33 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital
Insight
If You Cannot Pitch in Four Slides, You Haven't Mastered Your Story
“If you can't tell the story in four slides, you know, you just haven't really got your pitch down well”
Peter Parker Jun 11, 2018 ▶ 14:36 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital
Assertion Not checkable as stated
BioInnovation Capital Converts 100% of LPs Who Visit Their Lab Space
“When we can get an LP there, meaning this may say the second meeting is at our shop, I think we've gotten a hundred percent of those people to invest in the funds.”
Peter Parker Jun 11, 2018 ▶ 16:30 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital
Insight
VCs Should Not Invest in Their Own Internally Created Ideas
“I was sort of raised in the world that said, don't invest in your own ideas. Wait for the guy with passion to come in the front door and really sway you that this is an important idea.”
Peter Parker Jun 11, 2018 ▶ 24:01 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital
Prediction Not checkable as stated
BioInnovation Capital Targets Portfolio Exits Under $50M Total Funding
“So we like to say the companies have to be able to exit by the time fifty million dollars of venture money has gone in.”
Peter Parker Jun 11, 2018 ▶ 26:36 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital
Insight
Venture Capital Takes Ten Years to Begin Doing Well
“This is a hard business. I mean, I think it takes 10 years to even begin to do it well.”
Peter Parker Jun 11, 2018 ▶ 31:04 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital
Assertion Not checkable as stated
No VC Firms Called Themselves Life Sciences Funds in the Late 1980s
“So back in the late eighties, there were very few specialized firms at all. None that I knew of that would call themselves, for instance, life sciences firms.”
Peter Parker Jun 11, 2018 ▶ 5:35 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital
Insight
High-Performing VC Firms Rely on Detailed Systems and Process
“I think process is almost everything in good venture firms. If you get under the hood of any firm that you really respect, I think you'll find a very, very detailed process. Even though it looks chaotic, they have a pretty set system.”
Peter Parker Jun 11, 2018 ▶ 8:58 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital
Insight
Every Portfolio Company Inevitably Faces Major Trouble
“It's not a question of whether these companies are going to get into trouble. It's just a question of when.”
Peter Parker Jun 11, 2018 ▶ 9:59 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital
Insight
Startups Cannot Effectively Focus on More Than 10 Annual Objectives
“So beyond 10 objectives, we don't feel they can really be focusing on things that we think will change the outcome of the company.”
Peter Parker Jun 11, 2018 ▶ 18:30 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital
Insight
Failing Top Three Annual Objectives Indicates Serious Startup Problems
“Yeah, if companies aren't hitting their top two or three objectives, and if they're reasonable objectives, yeah, something's wrong.”
Peter Parker Jun 11, 2018 ▶ 19:54 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital
Disclosure
Peter Parker Has Replaced Approximately 15 CEOs Throughout His Career
“I mean, I've changed probably 15 CEOs in my life.”
Peter Parker Jun 11, 2018 ▶ 20:09 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital
Insight
CEO Goals Are Company Goals, Making Sustained Underperformance Impossible
“There's no difference between the CEO's goals and the company goals, and if they really are just lagging behind dramatically, then it's just not something you can sustain.”
Peter Parker Jun 11, 2018 ▶ 21:01 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital
Assertion Contradicted
Pharma Internal Research Headcount Dropped 5-6% Annually Over the Past Decade
“If you look at the last 10 years, the research headcount in pharma has gone down by five or six percentage points per annum, so they're half as big internal research, but now what they've done is created external R&D groups, so they're out shopping, and we hav…”
Peter Parker Jun 11, 2018 ▶ 24:49 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital
Insight
Investors Make Money in Winners, but Friends in Losers
“One that's kicking around in my head recently is, you know, back in September, Fred Wilson, in his blog, he quoted Brad Feld, who said that, you make money in winners, but you make friends in losers. And, you know, it's absolutely so true, and it's been very t…”
Peter Parker Jun 11, 2018 ▶ 29:27 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital
Assertion Contradicted
3M Post-It Note Was Invented to Communicate With CEO
“Three M is a great example of this, where the post-it note was famously invented by someone who just needed a way to communicate with the CEO on a piece of sticky paper.”
Peter Parker Jun 11, 2018 ▶ 3:47 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital
Assertion Not checkable as stated
The VC Industry Had Only 200 Firms Worldwide in the Late 1980s
“There were probably, we thought, maybe 200 venture firms in the world, and in those days, the U.S. Was the predominant player in venture capital. Now, this is early stage venture capital. A lot of these were efforts that spun out of investment banks or other e…”
Peter Parker Jun 11, 2018 ▶ 5:00 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital

The other half of the tape: Peter Parker's own voice is left out of every number here. Other people bring the name up 2 times in 1 episode on 20VC. every mention, with the transcript →

Who brings them up most Harry Stebbings 2

Every mention by year

tap a year for its mentions
0011212018episodesmentions
0112018episodes it came up in
0010.5212018episodesmentions per episode
2018 2 mentions in 1 episode

Appearances (1)

EpisodeDateSpeaking time
20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy Fo Jun 11, 2018 22m
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 1,200 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.

Try the podcast clipper Learn more